Eric T. Larson
7Patents
2h-index
15Co-inventors
40Inventor score
Filing activity: Jul 30, 2012 → Jan 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9765037B2 | Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases | Emerging Cross-Sectional Technologies | 7 | Active |
| US9975882B2 | Heteroaromatic compounds as BTK inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10307425B2 | Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseases | Emerging Cross-Sectional Technologies | 1 | Active |
| US10544104B2 | Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases | Emerging Cross-Sectional Technologies | 1 | Active |
| US11247972B2 | Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US10632122B2 | Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US9815822B2 | Heteroaromatic compounds as BTK inhibitors | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.